Home » Topics » Regulatory » EMA

EMA
RSS

EMA to review Gentium's MAA for defibrotide under accelerated assessment

June 2, 2011

EMA accepts Pfizer's regulatory filing for axitinib in renal cell carcinoma

June 2, 2011

EMA and Health Canada recommend revaccination with Ixiaro vaccine due to batch recall

May 30, 2011

EMA accepts for review Savient Pharmaceuticals' MAA for Krystexxa

May 30, 2011

NeuroSearch to conduct phase III confirmatory trial of Huntexil

May 26, 2011

CHMP issues negative trend vote on Bronchitol for cystic fibrosis

May 25, 2011

EMA's CHMP recommends label extension for tocilizumab

May 24, 2011

EMA committee recommends accelerated approval of Victrelis for hepatitis C genotype 1

May 23, 2011

CHMP recommends approval of Vibativ for nosocomial pneumonia caused by MRSA

May 23, 2011

GSK and Human Genome Sciences receive CHMP positive opinion for Benlysta

May 23, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...